Therefore, we examined the expression of PD-L1 in sarcoma cells treated with LFU and PTX combination in vitro and found that the expression of PD-L1 decreased in the combination group, suggesting that the combination treatment of LFU and PTX may enhance the anti-tumor immune response. Here, CD274 is linked to sarcoma.